New Jersey A1015 requires tobacco product retailers to stock and sell FDA-approved nicotine replacement therapy products.

New Jersey A1015 mandates that any entity selling tobacco products, excluding cigar shops, must stock and sell at least one type of FDA-approved nicotine replacement therapy product for tobacco cessation. These products must be displayed behind the sales counter, and the retailer must provide notice of their availability and display the NJ Smoking Quitline's logo, phone number, and website. The Commissioner of Health can set display requirements for these materials. Retailers have five business days to restock after selling out and must restock within 14 days.

New Jersey A1015 requires tobacco product retailers to stock and sell FDA-approved nicotine replacement therapy products.

New Jersey A1015 mandates that any entity selling tobacco products, excluding cigar shops, must stock and sell at least one type of FDA-approved nicotine replacement therapy product for tobacco cessation. These products must be displayed behind the sales counter, and the retailer must provide notice of their availability and display the NJ Smoking Quitline's logo, phone number, and website. The Commissioner of Health can set display requirements for these materials. Retailers have five business days to restock after selling out and must restock within 14 days.